Oakmont Corp’s Zimmer Biomet ZBH Stock Holding History

Oakmont Corp’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-202,539	Closed	-$23.1M	–	22
2015 Q1	$23.1M	Sell	202,539 -7,720	-4%	-$881K	3.41%	13
2014 Q4	$23.2M	Buy	210,259 +11,994	+6%	+$1.26M	3.71%	12
2014 Q3	$19.4M	Sell	198,265 -1,143	-0.6%	-$112K	3.48%	12
2014 Q2	$20.1M	Buy	+199,408	New	+$19.5M	3.4%	11

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oakmont Corp's ZBH Position: Q2 2015 in Review

Oakmont Corp sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 202,539 shares — an estimated $23.1M sold.

Oakmont Corp first reported a position in ZBH in Q2 2014 and held it in 4 quarters. The position peaked at $23.2M in Q4 2014. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Oakmont Corp reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Oakmont Corp sold 202,539 Zimmer Biomet shares in Q2 2015, an estimated $23.1M.
Oakmont Corp first reported a position in Zimmer Biomet in Q2 2014 and held it in 4 quarters.
Oakmont Corp's Zimmer Biomet position peaked at $23.2M in Q4 2014.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Oakmont Corp's 13F filing for Q2 2015, filed 13 Aug 2015.